NEW YORK, May 21 – Agilent Technologies said Monday it had reached an agreement with Harvard University to jointly develop nanopore technology for the analysis of nucleic acids.

The terms of the multiyear deal were not disclosed, but Agilent did say the project could be extended.

The company said it would work with Harvard to develop technology that converts nucleotide sequences into electronic signatures, helping to speed up the sequencing process. Agilent did not say when it expected to release nanopore technology to market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.